FDA Import Refusal SCS-8641260-9/41/1 — SATO-SEIYAKU CO., LTD
The FDA refused shipment SCS-8641260-9/41/1 from SATO-SEIYAKU CO., LTD (Japan) on Feb 10, 2020. The refused product falls under Drugs and Biologics — NAPHAZOLINE HCL (ADRENERGIC). Cited charges: 118,472
Refusal details
- Date
- Feb 10, 2020
- Country
- Japan
- Product Category
- Drugs and Biologics
- Product Code
- 60CBY46 NAPHAZOLINE HCL (ADRENERGIC)
- Charges
- 118,472